Arginine methyltransferase inhibitors and uses thereof
US9943504B2 · kind B2 · utility
14Cited by
42References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2016 |
| Grant date | Apr 17, 2018 |
| Priority date | — |
| Expiry date | Jun 10, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.